Multiple sclerosis and measles virus

Y Ohara1

  • 1Department of Microbiology, Kanazawa Medical University, Ishikawa, Japan. ohara@kanazawa-med.ac.jp

Insights

Investigating the measles virus (MV) as a potential cause of multiple sclerosis (MS), this study explores the link between early-life infections and demyelination. Definitive evidence remains elusive despite extensive virological research.

Area of Science:

  • Neurology
  • Virology
  • Immunology

Background:

  • Epidemiological data suggest infectious agents precede multiple sclerosis (MS) onset.
  • Virus-induced demyelination in animal models supports a viral trigger for MS.
  • Immunological links and neurological complications from measles virus (MV) implicate MV in MS.

Purpose of the Study:

  • To investigate the potential role of measles virus (MV) as a causative agent in multiple sclerosis (MS).
  • To explore the association between pre-pubertal infections and the development of MS.
  • To evaluate existing virological and immunological data linking MV to MS-related demyelination.

Main Methods:

  • Review of epidemiological studies on pre-pubertal exposures in MS patients.
  • Analysis of animal models demonstrating virus-induced demyelination.
  • Examination of virological research, including morphological studies, virus isolation, and gene detection for MV.
  • Assessment of immunological data and neurological complications associated with MV infection.

Main Results:

  • Epidemiological studies indicate a potential link between early-life infections and MS.
  • Animal models confirm viruses can induce demyelination.
  • MV has been investigated as a potential MS agent, with some supporting immunological data.
  • Despite numerous virological investigations, conclusive evidence directly identifying MV as the MS causative agent is still lacking.

Conclusions:

  • The hypothesis that measles virus (MV) may cause multiple sclerosis (MS) is supported by indirect evidence.
  • Further research is required to definitively establish or refute the role of MV in MS pathogenesis.
  • The search for infectious triggers of MS, particularly MV, remains an active area of investigation.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...